Milestone Pharmaceuticals Inc.
MIST
$1.32
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.70M | 76.42M | 83.25M | 89.48M | 66.00M |
| Total Receivables | 1.72M | 1.99M | 2.01M | 1.74M | 1.45M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.84M | 2.52M | 1.71M | 2.36M | 3.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 674.00K | 61.00K | 381.00K | 381.00K | 2.40M |
| Total Current Assets | 73.93M | 80.99M | 87.36M | 93.97M | 73.03M |
|
|
|||||
| Total Current Assets | 73.93M | 80.99M | 87.36M | 93.97M | 73.03M |
| Net Property, Plant & Equipment | 1.57M | 1.72M | 1.87M | 2.03M | 2.19M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 75.50M | 82.71M | 89.23M | 96.00M | 75.23M |
|
|
|||||
| Total Accounts Payable | 1.93M | 1.63M | 749.00K | 1.73M | 3.98M |
| Total Accrued Expenses | 5.62M | 3.05M | 3.25M | 1.85M | 2.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 571.00K | 582.00K | 567.00K | 555.00K | 546.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.13M | 5.26M | 4.57M | 4.13M | 7.23M |
|
|
|||||
| Total Current Liabilities | 8.13M | 5.26M | 4.57M | 4.13M | 7.23M |
| Long-Term Debt | 53.35M | 52.43M | 51.53M | 50.64M | 49.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 874.00K | 1.00M | 1.16M | 1.31M | 1.46M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 62.35M | 58.69M | 57.25M | 56.08M | 58.46M |
|
|
|||||
| Common Stock & APIC | 327.62M | 326.12M | 324.65M | 323.23M | 294.34M |
| Retained Earnings | -367.55M | -355.18M | -345.74M | -336.38M | -326.03M |
| Treasury Stock & Other | 53.08M | 53.08M | 53.08M | 53.08M | 48.46M |
| Total Common Equity | 13.15M | 24.01M | 31.98M | 39.92M | 16.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.15M | 24.01M | 31.98M | 39.92M | 16.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.15M | 24.01M | 31.98M | 39.92M | 16.77M |
|
|
|||||